I. To examine the feasibility, acceptability and preliminary efficacy of txt4AML in a pilot single arm study.
I. To explore the association between overall treatment responses and real-time oral anti-cancer medication (OAM) adherence.
I. To summarize and assess other patient-reported outcomes, collected either as patient chart review or through self-reported survey, as well as the patient post-intervention interviews.
Patients receive interactive text messages to help with adherence to medications and a smart pill bottle with medication reminders on study.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.